Off-Label Use of Topical Minoxidil in Alopecia: A Review


Topical minoxidil is a well-known and often-utilized drug in dermatological practice for the treatment of alopecia. It was approved by the United States Food and Drug Administration for the treatment of androgenetic alopecia in 1988. Since its approval, minoxidil has been used off-label for the treatment of many other types of alopecia, with minimal formal evidence of efficacy. Conditions for which the use of topical minoxidil has been reported include telogen effluvium, alopecia areata (AA), scarring alopecia, eyebrow hypotrichosis, monilethrix, and chemotherapy-induced alopecia (CIA). The evidence for the use of minoxidil in each condition is derived from a variety of studies, including clinical trials, case series, and case reports. A comprehensive review of the literature indicates that while minoxidil is routinely used in the management of many alopecic conditions, there is mixed evidence for its efficacy. For certain conditions, including AA and most scarring alopecias, the evidence seems to be inconclusive. For others, such as eyebrow hypotrichosis, monilethrix, early traction alopecia, and CIA, there is more support for the efficacy of minoxidil. Although the favorable safety profile of minoxidil is established in adults, its use in the treatment of pediatric alopecia may require heightened monitoring and patient education.

This is a preview of subscription content, log in to check access.


  1. 1.

    Gilmore E, Weil J, Chidsey C. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med. 1970;282(10):521–7.

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Gottlieb TB, Katz FH, Chidsey CA 3rd. Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine. Circulation. 1972;45(3):571–82.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Devine BL, Fife R, Trust PM. Minoxidil for severe hypertension after failure of other hypotensive drugs. Br Med J. 1977;2(6088):667–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  4. 4.

    Oka M, Makela M. Minoxidil in severe hypertension. Acta Med Scand. 1978;203(1–2):43–7.

    CAS  PubMed  Google Scholar 

  5. 5.

    Lester W. Hair-raising tale: no fame for men who discovered Rogaine. The Daily Gazette. 1996. p. 17.

  6. 6.

    US FDA. Rogaine (for Men). Report No.: NDA: 019501. Silver Spring, MD: US FDA

  7. 7.

    Associated Press. Hair-Growth Drug to Be Sold Over the Counter. New York Times. February 13, 1996.

  8. 8.

    Goh C, Zippin JH. Androgenetic alopecia: diagnosis and treatment with a focus on recent genetic implications. J Drugs Dermatol. 2009;8(2):185–92.

    PubMed  Google Scholar 

  9. 9.

    Koperski JA, Orenberg EK, Wilkinson DI. Topical minoxidil therapy for androgenetic alopecia. A 30-month study. Arch Dermatol. 1987;123(11):1483–7.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Rietschel RL, Duncan SH. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia. J Am Acad Dermatol. 1987;16(3 Pt 2):677–85.

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Wester RC, Maibach HI, Guy RH, Novak E. Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol. 1984;82(5):515–7.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186–94.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Varothai S, Bergfeld WF. Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):217–30.

    PubMed  Article  Google Scholar 

  14. 14.

    Phillips TG, Slomiany WP, Allison R. Hair loss: common causes and treatment. Am Fam Physician. 2017;96(6):371–8.

    PubMed  Google Scholar 

  15. 15.

    Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01–3.

    PubMed  PubMed Central  Google Scholar 

  16. 16.

    Hughes EC, Taneja A. Telogen effluvium. Treasure Island: StatPearls Publishing; 2018.

    Google Scholar 

  17. 17.

    Garcia-Hernandez MJ, Camacho FM. Chronic telogen effluvium: incidence, clinical and biochemical features, and treatment. Arch Dermatol. 1999;135(9):1123–4.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Arck PC, Handjiski B, Peters EM, Hagen E, Klapp BF, Paus R. Topical minoxidil counteracts stress-induced hair growth inhibition in mice. Exp Dermatol. 2003;12(5):580–90.

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Perera E, Sinclair R. Treatment of chronic telogen effluvium with oral minoxidil: a retrospective study. F1000Res. 2017;6:1650.

    PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Dmytriw AA, Morzycki W, Green PJ. Prevention of alopecia in medical and interventional chemotherapy patients. J Cutan Med Surg. 2015;19(1):11–6.

    PubMed  Article  Google Scholar 

  21. 21.

    Hordinsky M, Donati A. Alopecia areata: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):231–46.

    PubMed  Article  Google Scholar 

  22. 22.

    Galbraith GM, Thiers BH. In vitro suppression of human lymphocyte activity by minoxidil. Int J Dermatol. 1985;24(4):249–51.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Shi YP. Topical minoxidil in the treatment of alopecia areata and male-pattern alopecia. Arch Dermatol. 1986;122(5):506.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Fenton DA, Wilkinson JD. Topical minoxidil in the treatment of alopecia areata. Br Med J (Clin Res Ed). 1983;287(6398):1015–7.

    CAS  PubMed Central  Article  Google Scholar 

  25. 25.

    Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol. 1992;128(11):1467–73.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Chowdhury MM, Rahman MH, Wahab MA. Efficacy of combination therapy for the management regime of Alopecia areata. Mymensingh Med J. 2007;16(2 Suppl):S19–22.

    CAS  PubMed  Google Scholar 

  27. 27.

    White SI, Friedmann PS. Topical minoxidil lacks efficacy in alopecia areata. Arch Dermatol. 1985;121(5):591.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Vestey JP, Savin JA. A trial of 1% minoxidil used topically for severe alopecia areata. Acta Derm Venereol. 1986;66(2):179–80.

    CAS  PubMed  Google Scholar 

  29. 29.

    Shapiro J, Tan J, Ho V, Abbott F, Tron V. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. J Am Acad Dermatol. 1993;29(5 Pt 1):729–35.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Fransway AF, Muller SA. 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata. Cutis. 1988;41(6):431–5.

    CAS  PubMed  Google Scholar 

  31. 31.

    Price VH. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy. J Am Acad Dermatol. 1987;16(3 Pt 2):737–44.

    CAS  PubMed  Article  Google Scholar 

  32. 32.

    Farhangian ME, McMichael AJ, Huang KE, Feldman SR. Treatment of alopecia areata in the united states: a retrospective cross-sectional study. J Drugs Dermatol. 2015;14(9):1012–4.

    CAS  PubMed  Google Scholar 

  33. 33.

    Caldwell CC, Saikaly SK, Dellavalle RP, Solomon JA. Prevalence of pediatric alopecia areata among 572,617 dermatology patients. J Am Acad Dermatol. 2017;77(5):980–1.

    PubMed  Article  Google Scholar 

  34. 34.

    Xu L, Liu KX, Senna MM. A practical approach to the diagnosis and management of hair loss in children and adolescents. Front Med (Lausanne). 2017;4:112.

    PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Lenane P, Pope E, Krafchik B. Congenital alopecia areata. J Am Acad Dermatol. 2005;52(2 Suppl 1):8–11.

    PubMed  Article  Google Scholar 

  36. 36.

    Rai AK. Minoxidil-induced hypertrichosis in a child with alopecia areata. Indian Dermatol Online J. 2017;8(2):147–8.

    PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Herskovitz I, Freedman J, Tosti A. Minoxidil induced hypertrichosis in a 2 year-old child. 2013;F1000Res(2):226.

    Google Scholar 

  38. 38.

    Guerouaz N, Mohamed AO. Minoxidil induced hypertrichosis in children. Pan Afr Med J. 2014;18:8.

    PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Rampon G, Henkin C, de Souza PR, Almeida HL Jr. Infantile generalized hypertrichosis caused by topical minoxidil. An Bras Dermatol. 2016;91(1):87–8.

    PubMed  PubMed Central  Article  Google Scholar 

  40. 40.

    Georgala S, Befon A, Maniatopoulou E, Georgala C. Topical use of minoxidil in children and systemic side effects. Dermatology. 2007;214(1):101–2.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Tanus A, Oliveira CC, Villarreal DJ, Sanchez FA, Dias MF. Black women’s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity. Bras Dermatol. 2015;90(4):450–65.

    Article  Google Scholar 

  42. 42.

    Kossard S. Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol. 1994;130(6):770–4.

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Vano-Galvan S, Molina-Ruiz AM, Serrano-Falcon C, Arias-Santiago S, Rodrigues-Barata AR, Garnacho-Saucedo G, et al. Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol. 2014;70(4):670–8.

    PubMed  Article  Google Scholar 

  44. 44.

    Moreno-Ramirez D, Camacho Martinez F. Frontal fibrosing alopecia: a survey in 16 patients. J Eur Acad Dermatol Venereol. 2005;19(6):700–5.

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Racz E, Gho C, Moorman PW, Noordhoek Hegt V, Neumann HA. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review. J Eur Acad Dermatol Venereol. 2013;27(12):1461–70.

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Tosti A, Piraccini BM, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol. 2005;52(1):55–60.

    PubMed  Article  Google Scholar 

  47. 47.

    Esteban-Lucia L, Molina-Ruiz AM, Requena L. Update on frontal fibrosing alopecia. Actas Dermosifiliogr. 2017;108(4):293–304.

    CAS  PubMed  Article  Google Scholar 

  48. 48.

    Davis EC, Reid SD, Callender VD, Sperling LC. Differentiating central centrifugal cicatricial alopecia and androgenetic alopecia in african american men: report of three cases. J Clin Aesthet Dermatol. 2012;5(6):37–40.

    PubMed  PubMed Central  Google Scholar 

  49. 49.

    Herskovitz I, Miteva M. Central centrifugal cicatricial alopecia: challenges and solutions. Clin Cosmet Investig Dermatol. 2016;9:175–81.

    PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Miteva M, Tosti A. Pathologic diagnosis of central centrifugal cicatricial alopecia on horizontal sections. Am J Dermatopathol. 2014;36(11):859–64 (quiz 65–7).

    PubMed  Article  Google Scholar 

  51. 51.

    McMichael AJ. Ethnic hair update: past and present. J Am Acad Dermatol. 2003;48(6 Suppl):S127–33.

    PubMed  Article  Google Scholar 

  52. 52.

    Gathers RC, Lim HW. Central centrifugal cicatricial alopecia: past, present, and future. J Am Acad Dermatol. 2009;60(4):660–8.

    PubMed  Article  Google Scholar 

  53. 53.

    Eginli A, Dothard E, Bagayoko CW, Huang K, Daniel A, McMichael AJ. A retrospective review of treatment results for patients with central centrifugal cicatrical alopecia. J Drugs Dermatol. 2017;16(4):317–20.

    CAS  PubMed  Google Scholar 

  54. 54.

    Haskin A, Aguh C. All hairstyles are not created equal: what the dermatologist needs to know about black hairstyling practices and the risk of traction alopecia (TA). J Am Acad Dermatol. 2016;75(3):606–11.

    PubMed  Article  Google Scholar 

  55. 55.

    Samrao A, Price VH, Zedek D, Mirmirani P. The, “Fringe Sign”: a useful clinical finding in traction alopecia of the marginal hair line. Dermatol Online J. 2011;17(11):1.

    PubMed  Google Scholar 

  56. 56.

    Lawson CN, Hollinger J, Sethi S, Rodney I, Sarkar R, Dlova N, et al. Updates in the understanding and treatments of skin & hair disorders in women of color. Int J Womens Dermatol. 2015;1(2):59–75.

    PubMed  PubMed Central  Article  Google Scholar 

  57. 57.

    Khumalo NP, Ngwanya RM. Traction alopecia: 2% topical minoxidil shows promise. Report of two cases. J Eur Acad Dermatol Venereol. 2007;21(3):433–4.

    CAS  PubMed  Article  Google Scholar 

  58. 58.

    Barron-Hernandez YL, Tosti A. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia. Expert Opin Investig Drugs. 2017;26(4):515–22.

    CAS  PubMed  Article  Google Scholar 

  59. 59.

    Vergilis-Kalner IJ. Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases. Dermatol Online J. 2014;20:6.

    Google Scholar 

  60. 60.

    Suwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012;39(10):865–6.

    PubMed  Article  Google Scholar 

  61. 61.

    Civas E, Aksoy B, Aksoy HM, Eski M, Yucel K. Hair transplantation for therapy-resistant alopecia areata of the eyebrows: is it the right choice? J Dermatol. 2010;37(9):823–6.

    PubMed  Article  Google Scholar 

  62. 62.

    Toscani M, Fioramonti P, Ciotti M, Scuderi N. Single follicular unit hair transplantation to restore eyebrows. Dermatol Surg. 2011;37(8):1153–8.

    CAS  PubMed  Article  Google Scholar 

  63. 63.

    Lee S, Tanglertsampan C, Tanchotikul M, Worapunpong N. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study. J Dermatol. 2014;41(2):149–52.

    CAS  PubMed  Article  Google Scholar 

  64. 64.

    Sinclair R. Treatment of monilethrix with oral minoxidil. JAAD Case Rep. 2016;2(3):212–5.

    PubMed  PubMed Central  Article  Google Scholar 

  65. 65.

    Vikramkumar AG, Kuruvila S, Ganguly S. Monilethrix: a rare hereditary condition. Indian J Dermatol. 2013;58(3):243.

    PubMed  PubMed Central  Google Scholar 

  66. 66.

    Rossi A, Iorio A, Scali E, Fortuna MC, Mari E, Palese E, et al. Monilethrix treated with minoxidil. Int J Immunopathol Pharmacol. 2011;24(1):239–42.

    CAS  PubMed  Article  Google Scholar 

  67. 67.

    Oliveira EF, Araripe AL. Monilethrix: a typical case report with microscopic and dermatoscopic findings. An Bras Dermatol. 2015;90(1):126–7.

    PubMed  PubMed Central  Article  Google Scholar 

  68. 68.

    Singh G, Miteva M. Prognosis and management of congenital hair shaft disorders with fragility-part I. Pediatr Dermatol. 2016;33(5):473–80.

    PubMed  Article  Google Scholar 

  69. 69.

    Santos Z, Avci P, Hamblin MR. Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin Drug Discov. 2015;10(3):269–92.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  70. 70.

    Yeager CE, Olsen EA. Treatment of chemotherapy-induced alopecia. Dermatol Ther. 2011;24(4):432–42.

    PubMed  Article  Google Scholar 

  71. 71.

    Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol. 2008;26(34):5618–29.

    PubMed  Article  Google Scholar 

  72. 72.

    Shin H, Jo SJ, Kim DH, Kwon O, Myung SK. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer. 2015;136(5):E442–54.

    CAS  PubMed  Article  Google Scholar 

  73. 73.

    Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol. 1996;35(1):74–8.

    CAS  PubMed  Article  Google Scholar 

  74. 74.

    Granai CO, Frederickson H, Gajewski W, Goodman A, Goldstein A, Baden H. The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies. Eur J Gynaecol Oncol. 1991;12(2):129–32.

    CAS  PubMed  Google Scholar 

  75. 75.

    Rodriguez R, Machiavelli M, Leone B, Romero A, Cuevas MA, Langhi M, et al. Minoxidil (Mx) as a prophylaxis of doxorubicin-induced alopecia. Ann Oncol. 1994;5(8):769–70.

    CAS  PubMed  Article  Google Scholar 

  76. 76.

    Tallon B, Blanchard E, Goldberg LJ. Permanent chemotherapy-induced alopecia: case report and review of the literature. J Am Acad Dermatol. 2010;63(2):333–6.

    PubMed  Article  Google Scholar 

  77. 77.

    Kluger N, Jacot W, Frouin E, Rigau V, Poujol S, Dereure O, et al. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. Ann Oncol. 2012;23(11):2879–84.

    CAS  PubMed  Article  Google Scholar 

  78. 78.

    Tran D, Sinclair RD, Schwarer AP, Chow CW. Permanent alopecia following chemotherapy and bone marrow transplantation. Australas J Dermatol. 2000;41(2):106–8.

    CAS  PubMed  Article  Google Scholar 

  79. 79.

    Prevezas C, Matard B, Pinquier L, Reygagne P. Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer. Br J Dermatol. 2009;160(4):883–5.

    CAS  PubMed  Article  Google Scholar 

  80. 80.

    Yang X, Thai KE. Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil. Australas J Dermatol. 2016;57(4):e130–2.

    PubMed  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Stefan Vanderweil.

Ethics declarations

Conflict of interest

Jenna R. Stoehr, Jennifer N. Choi, Maria Colavincenzo, and Stefan Vanderweil have no conflicts of interest to declare.


No sources of funding were used for the preparation of this article.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stoehr, J.R., Choi, J.N., Colavincenzo, M. et al. Off-Label Use of Topical Minoxidil in Alopecia: A Review. Am J Clin Dermatol 20, 237–250 (2019).

Download citation